Literature DB >> 15691841

Participation of Rip2 in lipopolysaccharide signaling is independent of its kinase activity.

Chafen Lu1, Anlai Wang, Marion Dorsch, Jane Tian, Kumiko Nagashima, Anthony J Coyle, Bruce Jaffee, Timothy D Ocain, Yajun Xu.   

Abstract

Rip2 (Rick, Cardiak, CCK2, and CARD3) is a serine/threonine kinase containing a caspase recruitment domain (CARD) at the C terminus. Previous reports have shown that Rip2 is involved in multiple receptor signaling pathways that are important for innate and adaptive immune responses. However, it is not known whether Rip2 kinase activity is required for its function. Here we confirm that Rip2 participates in lipopolysaccharide (LPS)/Toll-like receptor (TLR4) signaling and demonstrate that its kinase activity is not required. Upon LPS stimulation, Rip2 was transiently recruited to the TLR4 receptor complex and associated with key TLR signaling mediators IRAK1 and TRAF6. Furthermore, Rip2 kinase activity was induced by LPS treatment. These data indicate that Rip2 is directly involved in the LPS/TLR4 signaling. Whereas macrophages from Rip2-deficient mice showed impaired NF-kappaB and p38 mitogen-activated protein kinase activation and reduced cytokine production in response to LPS stimulation, LPS signaling was intact in macrophages from mice that express Rip2 kinase-dead mutant. These results demonstrate that Rip2-mediated LPS signaling is independent of its kinase activity. Our findings strongly suggest that Rip2 functions as an adaptor molecule in transducing signals from immune receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691841     DOI: 10.1074/jbc.M410114200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  RICK/RIP2 is a NOD2-independent nodal point of gut inflammation.

Authors:  Tomohiro Watanabe; Kosuke Minaga; Ken Kamata; Toshiharu Sakurai; Yoriaki Komeda; Tomoyuki Nagai; Atsushi Kitani; Masaki Tajima; Ivan J Fuss; Masatoshi Kudo; Warren Strober
Journal:  Int Immunol       Date:  2019-09-18       Impact factor: 4.823

2.  Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.

Authors:  Yu-Jin Jeong; Min-Jung Kang; Sang-Jin Lee; Chang-Hwan Kim; Jee-Cheon Kim; Tae-Hyoun Kim; Dong-Jae Kim; Donghyun Kim; Gabriel Núñez; Jong-Hwan Park
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

3.  Differential Effect of Lactobacillus johnsonii BFE 6128 on Expression of Genes Related to TLR Pathways and Innate Immunity in Intestinal Epithelial Cells.

Authors:  Stephanie Seifert; Manuel Rodriguez Gómez; Bernhard Watzl; Wilhelm H Holzapfel; Charles M A P Franz; María G Vizoso Pinto
Journal:  Probiotics Antimicrob Proteins       Date:  2010-12       Impact factor: 4.609

4.  Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A.

Authors:  Theivanthiran Balamayooran; Sanjay Batra; Gayathriy Balamayooran; Shanshan Cai; Koichi S Kobayashi; Richard A Flavell; Samithamby Jeyaseelan
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.441

5.  Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Authors:  Jin Wang; Anatoly V Grishin; Henri R Ford
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

6.  CARD6 is interferon inducible but not involved in nucleotide-binding oligomerization domain protein signaling leading to NF-kappaB activation.

Authors:  Almut Dufner; Gordon S Duncan; Andrew Wakeham; Alisha R Elford; Håkan T Hall; Pamela S Ohashi; Tak W Mak
Journal:  Mol Cell Biol       Date:  2007-12-26       Impact factor: 4.272

7.  Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes.

Authors:  Unni Gopinathan; Reidun Ovstebø; Ole Kristoffer Olstad; Berit Brusletto; Hans Christian Dalsbotten Aass; Peter Kierulf; Petter Brandtzaeg; Jens Petter Berg
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

8.  TAK1 is a central mediator of NOD2 signaling in epidermal cells.

Authors:  Jae-Young Kim; Emily Omori; Kunihiro Matsumoto; Gabriel Núñez; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2007-10-26       Impact factor: 5.157

9.  The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-mediated immune responses.

Authors:  Chiara Nembrini; Jan Kisielow; Abdijapar T Shamshiev; Luigi Tortola; Anthony J Coyle; Manfred Kopf; Benjamin J Marsland
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

10.  The role of RIP2 in p38 MAPK activation in the stressed heart.

Authors:  Sebastien Jacquet; Yasuhiro Nishino; Sarawut Kumphune; Pierre Sicard; James E Clark; Koichi S Kobayashi; Richard A Flavell; Jan Eickhoff; Matt Cotten; Michael S Marber
Journal:  J Biol Chem       Date:  2008-02-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.